Kevin Allan Dooley

Auto part solution (invention) aimed at proactively reducing / eliminating car driver drowsiness and passenger car sickness.

Premise: Auto part solution (invention) aimed at proactively reducing / eliminating car driver drowsiness and passenger car sickness. Currently in the remaining 20% of invention's development (R&D). It's the size of a large coke bottle, world-wide patents pending (PCT has already come back with no prior art found). We are looking to license the IP to MAGNA for aftermarket distribution. Projected 80M end-users in North America (extremely conservative estimate). Financing Preference: Seed-level IP-backed securitization opportunity. We are seeking $400k in exchange for an 8X return paid back quarterly from our cash flow stream starting Q1 2017 and finishing at Q4 2019. Total repayment amount is $3.2M. Business Plan Access: SCREEN FRIENDLY: http://kevindooleyinc.com/wp-content/uploads/KAD_Inc_Business_Plan_Automotive_Aftermarket_Screen_Friendly.pdf PRINT FRIENDLY: http://kevindooleyinc.com/wp-content/uploads/KAD_Inc_Business_Plan_Automotive_Aftermarket_Print_Friendly.pdf *Both require this password to open: kadinc2014